Date: June 2007
Length: 00:12:14
Size: 5.60MB
Thought Leader: Ronald Kershner, Ph.D., Senior VP, Clinical Operations, inVentiv Clinical Solutions LLC
Dr. Kershner outlines the current state of play of EDC in the industry and the benefits the technology can bring to clinical studies, particularly access to real-time data and cost savings. Dr. Kershner also provides his insights to remaining adoption challenges.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, June 22, 2007
Why Validate?
Date: June 2007
Length: 00:11:39
Size: 5.33MB
Size: 5.33MB
Thought Leader: Chris Biddle, VP, Solutions Architecture, GHX Pharma Solutions
Good data validation practices for managed care can make a big impact on a pharmaceutical company's bottom line. This episode covers several important issues on this topic, including the general business environment for validation, why validation is important, Medicare Part D ramifications, primary causes of data errors, the ROI of validation, and more.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, June 21, 2007
Biological Drug Development
Date: June 2007
Length: 00:5:13
Size: 2.39MB
Thought Leader: William J. Newell, Executive VP, Aerovance
Mr. Newell discusses the uses of biologics in the development of asthma treatments, the challenges involved with biologic drug development, and considerations when designing a trial.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Size: 2.39MB
Thought Leader: William J. Newell, Executive VP, Aerovance
Mr. Newell discusses the uses of biologics in the development of asthma treatments, the challenges involved with biologic drug development, and considerations when designing a trial.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Biotechnology Business Trends
Date: June 2007
Length: 00:6:19
Size: 2.89MB
Thought Leader: Kenneth C. Carter, Ph.D., President and CEO, Avalon Pharmaceuticals
Dr. Carter talks about technology trends in the emerging biotechnology space, deal-making at the preclinical level, and Avalon's technology, a high-throughput discovery and development engine that is based on the total breadth of a cell's response at the genomic level to a drug.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Size: 2.89MB
Thought Leader: Kenneth C. Carter, Ph.D., President and CEO, Avalon Pharmaceuticals
Dr. Carter talks about technology trends in the emerging biotechnology space, deal-making at the preclinical level, and Avalon's technology, a high-throughput discovery and development engine that is based on the total breadth of a cell's response at the genomic level to a drug.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Seed Funding
Date: June 2007
Length: 00:3:41
Size: 1.68MB
Thought Leader:Barbara Schilberg, CEO, BioAdvance, Biotechnology Greenhouse of SE Pennsylvania
Ms. Schilberg discusses why it's important to invest in a new generation of life-sciences companies and how her organization is addressing a national problem — the gap in seed funding.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:3:41
Size: 1.68MB
Thought Leader:Barbara Schilberg, CEO, BioAdvance, Biotechnology Greenhouse of SE Pennsylvania
Ms. Schilberg discusses why it's important to invest in a new generation of life-sciences companies and how her organization is addressing a national problem — the gap in seed funding.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Global Biotechnology Trends
Date: June 2007
Length: 00:4:26
Size: 2.03MB
Thought Leader:Martyn Postle, Chairman and Chief Executive, Cambridge Healthcare & Biotech Ltd.
In this Podcast episode, Mr. Postle provides a top-line overview of global biotechnology trends based on results from a recent report — U.K. Drug Pipeline —completed by Cambridge Healthcare & Biotech.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Partnerships and Funding Opportunities
Date: June 2007
Length: 00:5:09
Size: 2.36MB
Thought Leader:Lucienne Cicurel, Ph.D., External Affairs Director, Debiopharm Group
Dr. Cicurel discusses trends in competition in the oncology space, best practices for partnerships, and funding for development.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Multimechanism Drugs
Date: June 2007
Length: 00:4:26
Size: 2.02MB
Thought Leader:James S. Burns, President and CEO, EntreMed Inc.
Mr. Burns talks about the advantages of multimechanism drugs to solve distinct development challenges in the oncology arena, the complexities of drug development, and the challenges associated with running a biotechnology company.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The State of Biotechnology in Kansas
Date: June 2007
Length: 00:3:56
Size: 1.80MB
Thought Leader: U.S. Senator Pat Roberts, U.S. Senator, Kansas; Tom Thornton, President and CEO, Kansas Biotech Authority, and Angela Krupps, President, Kansas BIO
State representatives discuss Kansas' biotechnology initiatives — health, agro, and biofuels — and what these mean to the state's economy.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:3:56
Size: 1.80MB
Thought Leader: U.S. Senator Pat Roberts, U.S. Senator, Kansas; Tom Thornton, President and CEO, Kansas Biotech Authority, and Angela Krupps, President, Kansas BIO
State representatives discuss Kansas' biotechnology initiatives — health, agro, and biofuels — and what these mean to the state's economy.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Macromolecule Development Trends
Date: June 2007
Length: 00:6:47
Size: 3.10MB
Thought Leader:Timothy Duffy, Executive VP, Marketing and Business Development, Nastech Pharmaceutical Co.
Mr. Duffy discusses how macromolecules — peptides and protein therapeutics — are expanding opportunities for development, partnering, therapeutic focus, and delivery of compounds.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:6:47
Size: 3.10MB
Thought Leader:Timothy Duffy, Executive VP, Marketing and Business Development, Nastech Pharmaceutical Co.
Mr. Duffy discusses how macromolecules — peptides and protein therapeutics — are expanding opportunities for development, partnering, therapeutic focus, and delivery of compounds.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
New R&D Model
Date: June 2007
Length: 00:12:56
Size: 5.92MB
Thought Leader: Jeff Davis, Head, Global New Business Development, and Kevin Driscoll, Ph.D., Director, Global New Technology Development, P&G Pharmaceuticals Inc.
Mr. Davis and Dr. Driscoll reveal P&G's outsourcing strategy for drug development, therapeutic areas of concentration, partnering strategies, and how the biotechnology component factors into the model.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:12:56
Size: 5.92MB
Thought Leader: Jeff Davis, Head, Global New Business Development, and Kevin Driscoll, Ph.D., Director, Global New Technology Development, P&G Pharmaceuticals Inc.
Mr. Davis and Dr. Driscoll reveal P&G's outsourcing strategy for drug development, therapeutic areas of concentration, partnering strategies, and how the biotechnology component factors into the model.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Integrated Development Strategies
Date: June 2007
Length: 00:6:51
Size: 3.13MB
Thought Leader: Stephen Keith Rhind, Ph.D., Senior VP, S*BIO Pte Ltd.
Dr. Rhind talks about the advantages of having integrated development capabilities, being based in Singapore in terms of patient recruitment, and the challenges involved in moving from discovery to development from a commercial perspective.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:6:51
Size: 3.13MB
Thought Leader: Stephen Keith Rhind, Ph.D., Senior VP, S*BIO Pte Ltd.
Dr. Rhind talks about the advantages of having integrated development capabilities, being based in Singapore in terms of patient recruitment, and the challenges involved in moving from discovery to development from a commercial perspective.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Hot Trends in the Biotech Sector
Date: June 2007
Length: 00:4:53
Size: 2.23MB
Thought Leader: Scott Ballenger, R.Ph., President, Trial Acceleration Institute
Mr. Ballenger discusses the hot trends in the biotech sector, such as the global nature of the industry, innovation, and what the promise of the industry holds.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:4:53
Size: 2.23MB
Thought Leader: Scott Ballenger, R.Ph., President, Trial Acceleration Institute
Mr. Ballenger discusses the hot trends in the biotech sector, such as the global nature of the industry, innovation, and what the promise of the industry holds.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)